ViroGates on Rights Issue 2022

23 June 2022 - 19:22
ViroGates' CEO Jakob Knudsen and CFO Mark da Silva present the highlights of the company's recently announced rights issue and answer questions from the audience. The session is moderated by Jens Jacob Aabel Nordkvist, Analyst at Västra Hamnen Corporate Finance....
Nasdaq First North GM Copenhagen (Denmark)
ViroGates A/S
ViroGates is a life science company that develops and sells prognostic products to the healthcare sector. The products are used in hospital emergency services, in particular to make a clinical decision on hospitalization or discharge of emergency patients....
Learn more about company

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More